Author Topic: Mediclinic - Patience or switch/sell?  (Read 9476 times)

Moonraker

  • Hero Member
  • *****
  • Posts: 1095
  • Karma: +31/-0
    • View Profile
Mediclinic - Patience or switch/sell?
« on: November 10, 2016, 02:48:43 pm »
Since I have bought Mediclinic in June 2014 one thing has become very clear to me.
You can't foresee the extent of government intervention in the shape of the Health Authorities
imposing co-payments on patients using private healthcare facilities (The Thiqa plan UAE).

In addition Switzerland will go the same way...
"The canton of Zurich is considering cost saving measures which may have an
impact on Klinik Hirslanden. The proposal in its current form (known as the VVG
levy) is to impose a tax on the proportion of privately insured patients treated
in listed hospitals."

With EPS down sharply and a poor outlook is there any reason to continue holding?
Why should things improve in 2 or 3 years - you can't take on government and win?

Spiralling down today after results.  >:(

jaDEB

  • Global Moderator
  • Hero Member
  • *****
  • Posts: 4534
  • Karma: +30/-3
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #1 on: November 10, 2016, 05:47:50 pm »
Sorry, cannot help u as I do not know them that well.

Just a question, if you would sell what are you thinking of buying?
jaDEB

If it scares you, it's a sign you need to do it

jaDEB

  • Global Moderator
  • Hero Member
  • *****
  • Posts: 4534
  • Karma: +30/-3
    • View Profile
jaDEB

If it scares you, it's a sign you need to do it

Moonraker

  • Hero Member
  • *****
  • Posts: 1095
  • Karma: +31/-0
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #3 on: November 11, 2016, 08:24:46 am »
Sorry, cannot help u as I do not know them that well.

Just a question, if you would sell what are you thinking of buying?

No, not selling. But if I were, my nemesis, resource stocks, are now a no brainer after Trump's victory. BHP. I have always avoided them in the past due to their cyclicality and volatility, and due to the fact that they are price takers (i.e. dependent on the underlying commodity prices). The upcoming potentially huge infrastructure spend under a Trump presidency means that things have changed for me regarding resources. Rising interest rates in the US and higher inflation also play a part. I am sure you agree 100%  ;)

jaDEB

  • Global Moderator
  • Hero Member
  • *****
  • Posts: 4534
  • Karma: +30/-3
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #4 on: November 11, 2016, 10:01:57 am »
Yip .   :TU: up on BIL  ;D
jaDEB

If it scares you, it's a sign you need to do it

Moonraker

  • Hero Member
  • *****
  • Posts: 1095
  • Karma: +31/-0
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #5 on: November 15, 2016, 08:37:33 am »
Mediclinic - No point in selling now.


Maurice

  • Jr. Member
  • **
  • Posts: 79
  • Karma: +3/-0
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #6 on: November 15, 2016, 02:18:00 pm »
Who was the Paul in the video?
I am down 30% in Mediclinic but see no reason to sell.  :wall:

Moonraker

  • Hero Member
  • *****
  • Posts: 1095
  • Karma: +31/-0
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #7 on: November 15, 2016, 03:26:29 pm »
Who was the Paul in the video?
I am down 30% in Mediclinic but see no reason to sell.  :wall:
Paul Theron from Vestact. http://www.vestact.co.za/

MoneyChief

  • Jr. Member
  • **
  • Posts: 78
  • Karma: +5/-0
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #8 on: November 15, 2016, 04:44:14 pm »
Who was the Paul in the video?
I am down 30% in Mediclinic but see no reason to sell.  :wall:

This is why I don't buy single stocks

Maurice

  • Jr. Member
  • **
  • Posts: 79
  • Karma: +3/-0
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #9 on: November 15, 2016, 06:55:38 pm »
Who was the Paul in the video?
I am down 30% in Mediclinic but see no reason to sell.  :wall:
Paul Theron from Vestact. http://www.vestact.co.za/
I recognised the voice but have only spoken to him on the phone. Anyway good to hear he likes Mediclinic

Moonraker

  • Hero Member
  • *****
  • Posts: 1095
  • Karma: +31/-0
    • View Profile
Re: Mediclinic - Patience or switch/sell?
« Reply #10 on: April 27, 2017, 10:03:08 am »
Some relief.. (Up nearly 18% as I type this).

ALLIANCE NEWS DETAIL


TOP NEWS: MEDICLINIC SHARES JUMP ON ABU DHABI REGULATORY CHANGE

[ 27 Apr 2017 08:21 ]
LONDON (Alliance News) - Shares in private healthcare business Mediclinic International PLC jumped Thursday morning following a reported regulatory change in Abu Dhabi, waiving co-payments for private medical treatment.

Shares in Mediclinic were up 11% at 810.00 pence Thursday, shortly after the market open, the best performer in the FTSE 100.

Mediclinic noted Thursday statements from the crown prince of Abu Dhabi. Crown Prince Mohamed bin Zayed Al Nahyan ordered the waiving of the 20% co-payment for holders of a Thiqa medical insurance card when receiving treatment at private healthcare facilities in Abu Dhabi. Mediclinic said it is awaiting precise details on these regulatory changes from the Health Authority of Abu Dhabi.

Mediclinic said it will continue to monitor the regulatory environment and the effect of these changes on its Middle East business. It operates six hospitals and 34 clinics in the UAE, and its Mediclinic Middle East business contributed 16% of revenue for its financial year ended in March.

By Hana Stewart-Smith; [email protected]; @HanaSSAllNews

AND the Swiss regulatory update on 10th April  ..
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.
 
10 April 2017
 
Swiss regulatory update
 
Mediclinic International plc, the international private healthcare group, today announces the following updates in the regulatory environment of Hirslanden, its operating platform in Switzerland.
 
In the Group's interim results announcement on 10 November 2016, Mediclinic stated that the canton of Zurich was considering a levy on the proportion of privately insured patients treated in listed hospitals, including Klinik Hirslanden, known as the VVG levy and that the Swiss national outpatient tariff ("TARMED") was still in revision.
 
On Monday, 10 April 2017, the Zurich Cantonal Parliament voted not to approve the proposed VVG levy.
 
On TARMED, the Swiss Federal Government has released proposed adjustments as a transitional solution whilst healthcare providers and funders continue to negotiate and agree a revised TARMED tariff structure. The government proposal is targeting annual savings of around CHF700m across the public and private outpatient sectors. Outpatient services contribute less than 20% of Hirslanden revenues. Due to its implementation date on 1 January 2018, the impact on Hirslanden is expected to be limited in the 2018 financial year (to 31 March 2018). Based on initial analyses of the complex proposal, the expected annualised impact on Hirslanden outpatient revenues could be around 10% before any mitigating actions are considered which could include improved utilisation and increased efficiencies.
 
The Zurich Cantonal Parliament has also approved an amendment to the cantonal hospital law, providing a legal basis for the cantonal government to create a list of interventions that in future should generally be treated as outpatient rather than inpatient services. The final list of interventions will be agreed following a working group review.
« Last Edit: April 27, 2017, 04:09:51 pm by Moonraker »